文献速递急性肾损伤

髓系CCR2促进急性肾损伤后动脉粥样硬化

Myeloid CCR2 Promotes Atherosclerosis after AKI.
PubMed 文献 · J Am Soc Nephrol · 2022-05-10

该研究在LDL受体缺陷小鼠中建立单侧肾缺血再灌注损伤后远端动脉粥样硬化增强模型,发现肾损伤后主动脉根部斑块显著增大,主动脉趋化因子及受体基因富集,CCR2+髓系细胞经CCR2介导归巢至缺血后肾脏,Ccr2-/-骨髓重建可抑制肾脏炎症并消除肾损伤后主动脉斑块增多。

要点

  • 肾缺血再灌注损伤后主动脉根部动脉粥样硬化病变较对照显著增大。
  • CCR2介导髓系细胞以细胞个体方式归巢至缺血后肾脏。
  • Ccr2-/-骨髓重建可抑制肾脏缺血后炎症并消除肾损伤后主动脉斑块增多。

核心结论

  • 研究提出肾缺血再灌注损伤远端促动脉粥样硬化效应的实验模型,并阐明髓系CCR2信号是机制性必要条件。
  • 作者认为在探讨肾损伤系统性血管后遗症时,应将单核细胞视为移动性介质。

研究设计与样本

  • 在天然及骨髓移植的LDL受体缺陷(LDLr-/-)小鼠中行单侧肾缺血再灌注损伤,采用组织学、流式细胞术和基因表达分析研究动脉粥样硬化病变与炎症。

主要发现

  • 肾缺血再灌注损伤后主动脉根部动脉粥样硬化病变较对照显著增大。
  • 基因表达筛查显示缺血再灌注损伤小鼠早期动脉粥样硬化主动脉中趋化因子及其同源受体富集,晚期疾病中T细胞相关基因富集。
  • 共聚焦显微镜显示主动脉巨噬细胞与T细胞邻近性增加。
  • 缺血再灌注损伤小鼠主动脉炎症基因调控差异与损伤肾脏模式大致平行。
  • 单细胞分析鉴定出产生动脉粥样硬化主动脉上调可溶性介质的肾脏细胞类型,并显示Ccl2早期显著增加,主要由CCR2+髓系细胞表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of cardiovascular events rises after AKI. Leukocytes promote atherosclerotic plaque growth and instability. We established a model of enhanced remote atherosclerosis after renal ischemia-reperfusion (IR) injury and investigated the underlying inflammatory mechanisms. METHODS: Atherosclerotic lesions and inflammation were investigated in native and bone marrow-transplanted LDL receptor-deficient (LDLr-/- ) mice after unilateral renal IR injury using histology, flow cytometry, and gene expression analysis. RESULTS: Aortic root atherosclerotic lesions were significantly larger after renal IR injury than in controls. A gene expression screen revealed enrichment for chemokines and their cognate receptors in aortas of IR-injured mice in early atherosclerosis, and of T cell-associated genes in advanced disease. Confocal microscopy revealed increased aortic macrophage proximity to T cells. Differential aortic inflammatory gene regulation in IR-injured mice largely paralleled the pattern in the injured kidney. Single-cell analysis identified renal cell types that produced soluble mediators upregulated in the atherosclerotic aorta. The analysis revealed a marked early increase in Ccl2, which CCR2+ myeloid cells mainly expressed. CCR2 mediated myeloid cell homing to the post-ischemic kidney in a cell-individual manner. Reconstitution with Ccr2-/- bone marrow dampened renal post-ischemic inflammation, reduced aortic Ccl2 and inflammatory macrophage marker CD11c, and abrogated excess aortic atherosclerotic plaque formation after renal IR. CONCLUSIONS: Our data introduce an experimental model of remote proatherogenic effects of renal IR and delineate myeloid CCR2 signaling as a mechanistic requirement. Monocytes should be considered as mobile mediators when addressing systemic vascular sequelae of kidney injury.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Hüsing AM, Wulfmeyer VC, Gaedcke S, et al. Myeloid CCR2 Promotes Atherosclerosis after AKI. J Am Soc Nephrol. 2022. PMID: 35537780. doi:10.1681/ASN.2022010048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。